Why did Teradyne's revenue and earnings grow so sharply year over year?

Revenue rose 87% to $1,282.5 million, driven primarily by AI-related demand across compute segments and memory, which management says accounts for about 70% of revenue. Semiconductor Test contributed $1,111 million of the total. Operating leverage amplified the gain: GAAP operating income rose to $473.0 million from $120.8 million, expanding the GAAP operating margin to 36.9% from 17.6%.

Is the Q2 2026 guidance a sign of slowing momentum?

The Q2 revenue guidance of $1,150–$1,250 million has a midpoint of $1,200 million, which is below Q1's $1,282.5 million. Guidance for non-GAAP EPS of $1.86–$2.15 also sits below Q1's $2.56. The release does not explain the drivers of the sequential decline, so investors should review the earnings call for management's commentary on order timing, customer mix, and the sustainability of AI-related demand.

Does the balance sheet or cash flow raise any concerns?

Accounts receivable rose $320.6 million in the quarter to $1,107.5 million, and the cash flow statement shows a $322.0 million working capital outflow from receivables. Operating cash flow of $265.1 million still exceeded net income's cash conversion needs, but the build in receivables tied to strong revenue is a timing item to monitor for collections. Cash and equivalents declined to $241.9 million, though the company repaid $200 million of short-term debt and retains $152 million in marketable securities.

What are the main risks highlighted in the filing?

The release cites macroeconomic conditions, dependence on significant customers, the pace of new product acceptance, growth in Robotics, tariffs and U.S. or Chinese export controls (including rules affecting Huawei and HiSilicon), geopolitical conflict, and supply chain constraints. Teradyne refers investors to its 2025 Form 10-K for a fuller discussion of these risks.

What is the difference between GAAP and non-GAAP results for Teradyne?

Non-GAAP results exclude acquired intangible amortization, restructuring and other charges, ERP implementation costs, inventory step-up, pension items, discrete tax adjustments, and the related tax effects. In Q1 2026 the gap was small: GAAP EPS was $2.53 versus non-GAAP EPS of $2.56. Non-GAAP results also exclude amortization of the Technoprobe equity-method investment, which is a notable adjustment for investors to understand when comparing earnings across periods.

TER 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed April 29, 2026. Cited figures are marked; the original filing is the authoritative source.

Teradyne (NASDAQ: TER) reported record first-quarter 2026 results for the period ended March 29, 2026, with revenue of $1,282.5 million^a, up 87% from $685.7 million a year earlier and up 18% sequentially from $1,083.3 million in Q4 2025.

GAAP net income was $398.9 million^b, or $2.53 per diluted share, compared with $0.61 in Q1 2025, and non-GAAP EPS was $2.56. Management attributed the results to AI-related demand, which it says represents approximately 70% of revenue, with Semiconductor Test contributing $1,111 million, Robotics $91 million, and Product Test $80 million. GAAP operating margin expanded to 36.9% from 27.1% in Q4 and 17.6% a year ago, and non-GAAP operating margin was 37.5%.

For Q2 2026, Teradyne guided revenue to $1,150 million to $1,250 million^c, GAAP EPS to $1.83 to $2.12, and non-GAAP EPS to $1.86 to $2.15. The guidance midpoint implies a sequential revenue decline from Q1's record level, so investors will want to understand whether the Q1 strength was lumpy or reflects a durable step-up in AI-driven demand. Balance sheet items warrant attention as well: accounts receivable rose to $1,107.5 million from $786.9 million, operating cash flow was $265.1 million, and the company repaid a net $200 million on its revolving credit facility, reducing short-term debt to zero.

Free cash flow after $64.7 million^d in capital expenditures was roughly $200 million. The filing is an 8-K under Item 2.02 that furnishes the earnings press release as Exhibit 99.1. The release does not contain new forward-looking commitments beyond the Q2 guidance, and it references the Form 10-K for the fiscal year ended December 31, 2025 for a full discussion of risk factors, including export controls, tariffs, and customer concentration.

02—Key points

Key Highlights

Record Q1 2026 revenue of $1,282.5 million, up 87% year over year and 18% sequentially, with all three business groups growing year over year.
GAAP diluted EPS of $2.53 versus $0.61 in Q1 2025; non-GAAP diluted EPS of $2.56 versus $0.75.
GAAP operating margin of 36.9% (non-GAAP 37.5%), up from 17.6% a year earlier, reflecting strong operating leverage.
Management states approximately 70% of revenue is tied to AI-related demand; Semiconductor Test generated $1,111 million of the quarter's revenue.
Q2 2026 guidance of $1,150–$1,250 million in revenue and $1.86–$2.15 non-GAAP EPS, with the midpoint implying a sequential decline from Q1.
Accounts receivable increased sharply to $1,107.5 million from $786.9 million, while operating cash flow was $265.1 million and the company repaid $200 million of short-term debt.
Quarterly dividend increased to $0.13 per share from $0.12, and share count continued to decline year over year (diluted shares 157.6 million vs. 162.0 million).

03—Questions

Frequently Asked Questions

Why did Teradyne's revenue and earnings grow so sharply year over year?
Revenue rose 87% to $1,282.5 million, driven primarily by AI-related demand across compute segments and memory, which management says accounts for about 70% of revenue. Semiconductor Test contributed $1,111 million of the total. Operating leverage amplified the gain: GAAP operating income rose to $473.0 million from $120.8 million, expanding the GAAP operating margin to 36.9% from 17.6%.
Is the Q2 2026 guidance a sign of slowing momentum?
The Q2 revenue guidance of $1,150–$1,250 million has a midpoint of $1,200 million, which is below Q1's $1,282.5 million. Guidance for non-GAAP EPS of $1.86–$2.15 also sits below Q1's $2.56. The release does not explain the drivers of the sequential decline, so investors should review the earnings call for management's commentary on order timing, customer mix, and the sustainability of AI-related demand.
Does the balance sheet or cash flow raise any concerns?
Accounts receivable rose $320.6 million in the quarter to $1,107.5 million, and the cash flow statement shows a $322.0 million working capital outflow from receivables. Operating cash flow of $265.1 million still exceeded net income's cash conversion needs, but the build in receivables tied to strong revenue is a timing item to monitor for collections. Cash and equivalents declined to $241.9 million, though the company repaid $200 million of short-term debt and retains $152 million in marketable securities.
What are the main risks highlighted in the filing?
The release cites macroeconomic conditions, dependence on significant customers, the pace of new product acceptance, growth in Robotics, tariffs and U.S. or Chinese export controls (including rules affecting Huawei and HiSilicon), geopolitical conflict, and supply chain constraints. Teradyne refers investors to its 2025 Form 10-K for a fuller discussion of these risks.
What is the difference between GAAP and non-GAAP results for Teradyne?
Non-GAAP results exclude acquired intangible amortization, restructuring and other charges, ERP implementation costs, inventory step-up, pension items, discrete tax adjustments, and the related tax effects. In Q1 2026 the gap was small: GAAP EPS was $2.53 versus non-GAAP EPS of $2.56. Non-GAAP results also exclude amortization of the Technoprobe equity-method investment, which is a notable adjustment for investors to understand when comparing earnings across periods.

04—Continue

← View all 8-K filings